top of page
Taran Therapeutics
Writer
Corporate Communications
More actions
Profile
Join date: Sep 2, 2025
Posts (3)
Aug 1, 2025 ∙ 8 min
Taran Therapeutics Presents Promising Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia and Secondary Acute Myeloid Leukemia Treatment
Taran Therapeutics Presents Promising Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia and Secondary Acute Myeloid Leukemia Treatment
17
0
Jul 28, 2025 ∙ 8 min
Taran Therapeutics Reports Publication from PREACH-M Trial for Chronic Myelomonocytic Leukemia in Current Edition of the European Medical Journal
Taran Therapeutics Reports Publication from PREACH-M Trial for Chronic Myelomonocytic Leukemia in Current Edition of the European Medical Journal
6
0
Jun 1, 2025 ∙ 4 min
Publication of Provisional Patent Application for Lenzilumab in Chronic Myelomonocytic Leukemia (CMML)
Publication of Provisional Patent Application for Lenzilumab in Chronic Myelomonocytic Leukemia (CMML)
8
0
bottom of page